203 related articles for article (PubMed ID: 23463177)
1. Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases.
Nishimura Y; Maeda M; Kumagai-Takei N; Lee S; Matsuzaki H; Wada Y; Nishiike-Wada T; Iguchi H; Otsuki T
Environ Health Prev Med; 2013 May; 18(3):198-204. PubMed ID: 23463177
[TBL] [Abstract][Full Text] [Related]
2. Impairment in cytotoxicity and expression of NK cell- activating receptors on human NK cells following exposure to asbestos fibers.
Nishimura Y; Miura Y; Maeda M; Kumagai N; Murakami S; Hayashi H; Fukuoka K; Nakano T; Otsuki T
Int J Immunopathol Pharmacol; 2009; 22(3):579-90. PubMed ID: 19822075
[TBL] [Abstract][Full Text] [Related]
3. Functional Alteration of Natural Killer Cells and Cytotoxic T Lymphocytes upon Asbestos Exposure and in Malignant Mesothelioma Patients.
Nishimura Y; Kumagai-Takei N; Matsuzaki H; Lee S; Maeda M; Kishimoto T; Fukuoka K; Nakano T; Otsuki T
Biomed Res Int; 2015; 2015():238431. PubMed ID: 26161391
[TBL] [Abstract][Full Text] [Related]
4. Search for biomarkers of asbestos exposure and asbestos-induced cancers in investigations of the immunological effects of asbestos.
Matsuzaki H; Kumagai-Takei N; Lee S; Maeda M; Sada N; Hatayama T; Yamamoto S; Ikeda M; Yoshitome K; Min Y; Nishimura Y; Otsuki T
Environ Health Prev Med; 2017 Jun; 22(1):53. PubMed ID: 29165150
[TBL] [Abstract][Full Text] [Related]
5. [Immunological aspects of asbestos-related diseases].
Kanceljak-Macan B
Arh Hig Rada Toksikol; 2009 Nov; 60 Suppl():45-50. PubMed ID: 20853778
[TBL] [Abstract][Full Text] [Related]
6. Suppressive effect of asbestos on cytotoxicity of human NK cells.
Nishimura Y; Kumagai N; Maeda M; Hayashi H; Fukuoka K; Nakano T; Miura Y; Hiratsuka J; Otsuki T
Int J Immunopathol Pharmacol; 2011; 24(1 Suppl):5S-10S. PubMed ID: 21329559
[TBL] [Abstract][Full Text] [Related]
7. Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers.
Lee S; Matsuzaki H; Maeda M; Yamamoto S; Kumagai-Takei N; Hatayama T; Ikeda M; Yoshitome K; Nishimura Y; Otsuki T
Int J Oncol; 2017 Jan; 50(1):66-74. PubMed ID: 27878235
[TBL] [Abstract][Full Text] [Related]
8. Lung asbestos burden in shipyard and construction workers with mesothelioma: comparison with burdens in subjects with asbestosis or lung cancer.
Warnock ML
Environ Res; 1989 Oct; 50(1):68-85. PubMed ID: 2792062
[TBL] [Abstract][Full Text] [Related]
9. Induction of IL-17 production from human peripheral blood CD4+ cells by asbestos exposure.
Maeda M; Chen Y; Lee S; Kumagai-Takei N; Yoshitome K; Matsuzaki H; Yamamoto S; Hatayama T; Ikeda M; Nishimura Y; Otsuki T
Int J Oncol; 2017 Jun; 50(6):2024-2032. PubMed ID: 28498408
[TBL] [Abstract][Full Text] [Related]
10. [Respiratory malignancies induced by asbestos exposure and evaluation of cases with typical pleural malignant mesothelioma and lung cancer with asbestosis].
Kishimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1078-84. PubMed ID: 2243458
[TBL] [Abstract][Full Text] [Related]
11. Functional properties of CD8(+) lymphocytes in patients with pleural plaque and malignant mesothelioma.
Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Kishimoto T; Fukuoka K; Nakano T; Otsuki T
J Immunol Res; 2014; 2014():670140. PubMed ID: 25045719
[TBL] [Abstract][Full Text] [Related]
12. The alveolar macrophage: immune derangement and asbestos-related malignancy.
Kagan E
Semin Oncol; 1981 Sep; 8(3):258-67. PubMed ID: 7280710
[No Abstract] [Full Text] [Related]
13. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues.
Markowitz S
Semin Respir Crit Care Med; 2015 Jun; 36(3):334-46. PubMed ID: 26024342
[TBL] [Abstract][Full Text] [Related]
14. Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.
Attanoos RL; Thomas DH; Gibbs AR
Histopathology; 2003 Oct; 43(4):387-92. PubMed ID: 14511258
[TBL] [Abstract][Full Text] [Related]
15. Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients.
Maeda M; Nishimura Y; Hayashi H; Kumagai N; Chen Y; Murakami S; Miura Y; Hiratsuka J; Kishimoto T; Otsuki T
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):795-803. PubMed ID: 21357438
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of asbestos-induced lung disease.
Liu G; Cheresh P; Kamp DW
Annu Rev Pathol; 2013 Jan; 8():161-87. PubMed ID: 23347351
[TBL] [Abstract][Full Text] [Related]
17. Asbestos exposure increases the incidence of histologically confirmed usual interstitial pneumonia.
Kawabata Y; Shimizu Y; Hoshi E; Murai K; Kanauchi T; Kurashima K; Sugita Y
Histopathology; 2016 Feb; 68(3):339-46. PubMed ID: 26046696
[TBL] [Abstract][Full Text] [Related]
18. Asbestos content of lung tissue in asbestos associated diseases: a study of 110 cases.
Roggli VL; Pratt PC; Brody AR
Br J Ind Med; 1986 Jan; 43(1):18-28. PubMed ID: 3947558
[TBL] [Abstract][Full Text] [Related]
19. Distinction between mesothelioma and lung adenocarcinoma based on immunohistochemistry in a patient with asbestos bodies in bronchoalveolar fluid - case report.
Raşcu A; Naghi E; OŢelea MR; NiŢu FM; Arghir OC
Rom J Morphol Embryol; 2016; 57(3):1171-1174. PubMed ID: 28002541
[TBL] [Abstract][Full Text] [Related]
20. [Pleural mesothelioma in a school teacher: asbestos exposure due to DAS paste].
Barbieri PG; Somigliana A; Girelli R; Lombardi S; Sarnico M; Silvestri S
Med Lav; 2016 Mar; 107(2):141-7. PubMed ID: 27015029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
